LRMR Larimar Therapeutics, Inc. - Common Stock
$4,23
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 4, 2026
52W-Spanne
$3–$6
41% of range
Analystenbewertung
STRONG BUY
17 analysts
Kursziel
$14
+238% upside
P/E (TTM)
-2.5
ROE
-167.4%
Nettogewinnmarge
—
Über Larimar Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
LRMR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.23
Marktkapitalisierung
$351M
P/E (TTM)
-2.5
EPS (TTM)
$-1.32
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-167.4%
Verschuldungsgrad
—
52W-Spanne
$3 – $6
LRMR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
2016-12-31
→
2019-12-31
EPS
$-1.32
2020-12-31
→
2024-12-31
Freier Cashflow
$-113M
2016-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
LRMR
Peer-Median
P/E (TTM)
-2.5
17.4
P/B (K/B)
4.5
4.8
Price / FCF (Kurs / FCF)
-3.1
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
LRMR
Peer-Median
ROA
-95.8%
-41.1%
ROE
-167.4%
-52.6%
ROIC
-220.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
LRMR
Peer-Median
Current Ratio (Liquiditätsgrad)
2.2
7.7
Quick Ratio
1.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
LRMR
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
LRMR
Peer-Median
LRMR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
17 Analysten
- Starker Kauf 8 47,1%
- Kauf 8 47,1%
- Halten 1 5,9%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-18
Median
$12.50
Mittelwert
$14.30
← Unter allen Zielen
$4.23
Tief
$5.00
Hoch
$26.00
Median-Ziel
$12.50
+195,5%
Mittelwert-Ziel
$14.30
+238,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.30 | $-0.39 | 0.09% |
| 31. März 2026 | $-0.31 | $-0.55 | 0.24% |
| 31. Dezember 2025 | $-0.73 | $-0.52 | -0.21% |
| 30. September 2025 | $-0.61 | $-0.41 | -0.20% |
| 30. Juni 2025 | $-0.41 | $-0.49 | 0.08% |
| 31. März 2025 | $-0.46 | $-0.43 | -0.03% |
| 31. Dezember 2024 | $-0.45 | $-0.32 | -0.13% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $154M | $73M | $28M | $24M | $38M | $31M | $21M | $48M | $41M | $40M | $55M | $27M | |
| SG&A Expense | $18M | $18M | $14M | $12M | $12M | $11M | $2M | $13M | $12M | $18M | $19M | $8M | |
| Operating Expenses | $172M | $91M | $42M | $37M | $50M | $43M | $23M | $61M | $53M | $58M | $74M | $36M | |
| Operating Income | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-23M | $-61M | $-53M | $-58M | $-74M | $-36M | |
| Interest Expense | · | · | · | · | · | · | $2M | $2M | $165.0K | $529.0K | $806.0K | $870.0K | |
| Interest Income | · | · | · | · | · | · | $2M | $2M | $996.0K | · | · | · | |
| Other Non-op | $7M | $10M | $5M | $1M | $-171.0K | $322.0K | $82.0K | $-246.0K | $971.0K | $347.0K | $-473.0K | $-946.0K | |
| Pretax Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| EPS (Basic) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| Shares (Basic) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| EBITDA | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-46M | $-61M | $-53M | $-58M | · | $-36M |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $33M | $27M | $27M | $70M | $68M | $1M | $49M | $41M | $32M | $36M | $58M | |
| Prepaid Expense | $5M | $12M | $3M | $2M | $2M | $5M | $4M | $2M | $2M | $1M | $2M | $1M | |
| Current Assets | $142M | $195M | $90M | $121M | $72M | $98M | $5M | $121M | $105M | $131M | $188M | $117M | |
| PP&E (Net) | $622.0K | $881.0K | $684.0K | $831.0K | $1M | $1M | $274.0K | $375.0K | $528.0K | $661.0K | $902.0K | $79.0K | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $2M | $1M | $453.0K | $925.0K | $1M | $981.0K | $1M | $129.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $914.0K | $596.0K | $335.0K | $179.0K | $550.0K | $508.0K | $320.0K | $120.0K | $50.0K | |
| Other Non-current Assets | $523.0K | $596.0K | $659.0K | $638.0K | $669.0K | $419.0K | $90.0K | $57.0K | $57.0K | $61.0K | $94.0K | $242.0K | |
| Total Assets | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Accounts Payable | $5M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $3M | $3M | $7M | $2M | |
| Accrued Liabilities | $58M | $21M | $7M | $8M | $7M | $6M | $2M | $4M | $4M | $4M | $6M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | $3M | $1M | |
| Current Liabilities | $65M | $24M | $10M | $11M | $9M | $9M | $6M | $13M | $7M | $10M | $17M | $7M | |
| Capital Leases | $3M | $4M | $5M | $5M | $5M | $6M | $6M | · | · | · | · | · | |
| Total Liabilities | $68M | $28M | $14M | $16M | $14M | $15M | $6M | $28M | $27M | $10M | $20M | $13M | |
| Long-term Debt | · | · | · | · | · | · | $15M | $20M | $20M | $3M | · | · | |
| Total Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | · | $1M | |
| Common Stock | $83.0K | $64.0K | $43.0K | $43.0K | $18.0K | $15.0K | $6.0K | $37.0K | $27.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $513M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-435M | $-269M | $-189M | $-152M | $-116M | $-66M | $-23M | $-351M | $-290M | $-238M | $-180M | $-105M | |
| AOCI | $54.0K | $148.0K | $81.0K | $-31.0K | · | $1.0K | $35.0K | $-33.0K | $-58.0K | $-80.0K | $-207.0K | $-35.0K | |
| Stockholders' Equity | $78M | $172M | $82M | $111M | $64M | $90M | $-694.0K | $3M | $78M | $122M | $169M | $104M | |
| Liabilities + Equity | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Shares Outstanding | 83,090,392 | 63,815,065 | 43,909,069 | 43,269,200 | 17,710,450 | 15,367,730 | 6,091,250 | 37,287,221 | 27,489,457 | 27,332,551 | 27,242,503 | 22,879,160 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $9M | $8M | $7M | $5M | $2M | $129.0K | $10M | $8M | $10M | $9M | $2M | |
| Restructuring | · | · | · | · | · | · | $6M | · | · | $1M | · | · | |
| Operating Cash Flow | $-113M | $-71M | $-33M | $-28M | $-42M | $-42M | $-23M | $-51M | $-44M | $-52M | $-60M | $-28M | |
| CapEx | $91.0K | $515.0K | $164.0K | $100.0K | $333.0K | $62.0K | $83.0K | $108.0K | $55.0K | $660.0K | $595.0K | $58.0K | |
| Investing Cash Flow | $100M | $-85M | $33M | $-91M | $24M | $17M | $-83.0K | $-7M | $36M | $51M | · | · | |
| Stock Issued | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | $130M | $103M | |
| Net Stock Activity | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | · | · | |
| Financing Cash Flow | $65M | $162M | $30.0K | $75M | $20M | $94M | $19M | $67M | $17M | $-3M | · | · | |
| Net Change in Cash | $52M | $6M | $-76.0K | $-43M | $2M | $68M | $-3M | $9M | $8M | $-3M | $-23M | $23M | |
| Free Cash Flow | $-113M | $-71M | $-34M | $-28M | $-42M | $-42M | $-42M | $-52M | $-44M | $-53M | · | $-28M | |
| Levered FCF | · | · | · | · | · | · | $-43M | $-53M | $-44M | $-53M | · | $-29M |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -95.8% | -54.4% | -33.2% | -34.5% | -55.2% | -77.3% | -44.9% | -54.0% | -43.9% | -36.1% | · | -46.9% | |
| ROE | -167.4% | -43.5% | -42.4% | -30.8% | -74.2% | -44.2% | -163.6% | -62.2% | -52.0% | -39.8% | · | -203.4% | |
| ROIC | -220.9% | -52.9% | -51.1% | -32.9% | -78.3% | -47.7% | -75.0% | -61.9% | -67.8% | -46.5% | · | -33.6% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | · | 17.0 | |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 | 7.6 | 2.2 | 3.7 | 5.6 | 3.3 | · | 8.4 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | -25.9 | -32.2 | -321.2 | -110.1 | · | -40.8 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 |
Bewertung (TTM) 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Market Cap | $317M | $247M | $200M | $179M | $191M | $329M | $499M | $2.21B | $1.52B | $1.04B | · | $8.47B | |
| Enterprise Value | · | · | · | · | · | · | $479M | $2.17B | · | $1.01B | · | $8.41B | |
| P/E | -2.2 | -2.9 | -5.4 | -3.0 | -3.7 | -6.0 | · | · | · | · | · | · | |
| P/B | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | 9.3 | 23.7 | 19.5 | 8.6 | · | 81.1 | |
| P / Tangible Book | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | -3.5 | -6.0 | -6.5 | -4.5 | -7.8 | -12.2 | -43.0 | -34.8 | -20.1 | · | -299.8 | |
| P / FCF | -2.8 | -3.5 | -5.9 | -6.5 | -4.5 | -7.8 | -12.0 | -42.9 | -34.8 | -19.8 | · | -299.2 | |
| EV / EBITDA | · | · | · | · | · | · | -10.5 | -35.5 | · | -17.4 | · | -236.7 | |
| EV / FCF | · | · | · | · | · | · | -11.5 | -42.1 | · | -19.3 | · | -297.2 | |
| Earnings Yield | -45.1% | -34.1% | -18.5% | -33.2% | -27.3% | -16.7% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $25M | $59M | $45M | $23M | $27M | $27M | $14M | $20M | $13M | $11M | $7M | $6M | $5M | $7M | $6M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $34M | $31M | $64M | $49M | $28M | $31M | $31M | $18M | $25M | $17M | $14M | $10M | $10M | $8M | $10M | $9M | |
| Operating Income | $-34M | $-31M | $-64M | $-49M | $-28M | $-31M | $-31M | $-18M | $-25M | $-17M | $-14M | $-10M | $-10M | $-8M | $-10M | $-9M | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $193.0K | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-33M | $-30M | $-62M | $-48M | $-26M | $-29M | $-29M | $-15M | $-22M | $-15M | $-13M | $-9M | $-8M | $-7M | $-9M | $-8M | |
| EPS (Basic) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| EPS (Diluted) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| Shares (Basic) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | -87,797,703 | 43,903,738 | 43,897,603 | 43,897,603 | -33,144,540 | 22,228,228 | |
| Shares (Diluted) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | -87,797,703 | 43,903,738 | 43,897,603 | 43,897,603 | -33,144,540 | 22,228,228 | |
| EBITDA | $-34M | $-31M | · | $-49M | $-28M | $-31M | · | $-18M | $-25M | $-17M | · | $-10M | $-10M | $-8M | · | $-9M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $178M | $85M | $90M | $21M | $21M | $33M | $35M | $32M | $110M | $27M | $39M | $94M | $112M | $27M | $86M | |
| Prepaid Expense | $4M | $5M | $5M | $8M | $7M | $8M | $12M | $10M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $161M | $205M | $142M | $183M | $146M | $165M | $195M | $213M | $231M | $231M | $90M | $98M | $106M | $113M | $121M | $127M | |
| PP&E (Net) | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K | $844.0K | $604.0K | $684.0K | $601.0K | $677.0K | $753.0K | $831.0K | $909.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $914.0K | $836.0K | |
| Other Non-current Assets | $480.0K | $504.0K | $523.0K | $542.0K | $561.0K | $582.0K | $596.0K | $621.0K | $636.0K | $678.0K | $659.0K | $634.0K | $644.0K | $632.0K | $638.0K | $643.0K | |
| Total Assets | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Accounts Payable | $8M | $9M | $5M | $11M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $756.0K | $2M | $695.0K | $2M | $849.0K | |
| Accrued Liabilities | $25M | $38M | $58M | $33M | $21M | $19M | $21M | $14M | $17M | $10M | $7M | $5M | $4M | $7M | $8M | $8M | |
| Current Liabilities | $34M | $48M | $65M | $45M | $27M | $22M | $24M | $16M | $21M | $13M | $10M | $7M | $7M | $8M | $11M | $9M | |
| Capital Leases | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Liabilities | $38M | $50M | $68M | $48M | $30M | $26M | $28M | $21M | $26M | $17M | $14M | $11M | $12M | $13M | $16M | $14M | |
| Common Stock | $103.0K | $103.0K | $83.0K | $86.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | |
| Paid-in Capital | $625M | $622M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-497M | $-464M | $-435M | $-372M | $-325M | $-298M | $-269M | $-240M | $-225M | $-203M | $-189M | $-176M | $-166M | $-158M | $-152M | $-142M | |
| AOCI | $-12.0K | $6.0K | $54.0K | $66.0K | $-9.0K | $54.0K | $148.0K | $358.0K | $-150.0K | $-25.0K | $81.0K | $7.0K | $12.0K | · | $-31.0K | $-40.0K | |
| Stockholders' Equity | $127M | $158M | $78M | $139M | $120M | $144M | $172M | $198M | $211M | $231M | $82M | $93M | $100M | $106M | $111M | $119M | |
| Liabilities + Equity | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Shares Outstanding | 103,882,937 | 103,882,937 | 83,090,392 | 85,590,392 | 64,027,892 | 64,027,892 | 63,815,065 | 63,806,628 | 63,802,517 | 63,800,017 | 43,909,069 | 43,905,903 | 43,269,200 | 43,269,200 | 43,269,200 | 43,269,200 |
Cashflow 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-44M | $-45M | · | · | $-19M | $-27M | $-22M | $-25M | $-14M | $-10M | $-9M | $-9M | $-7M | $-8M | $-7M | $-6M | |
| CapEx | · | · | $0 | $23.0K | $19.0K | $49.0K | $179.0K | $62.0K | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-41M | $29M | · | · | $19M | $14M | $19M | $27M | $-63M | $-68M | $-3M | $-46M | $-10M | $92M | $-52M | $-3M | |
| Stock Issued | · | · | $-201.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-435.0K | $108M | · | · | · | · | $36.0K | $30.0K | $-334.0K | $162M | $0 | · | · | · | $-316.0K | · | |
| Net Change in Cash | $-85M | $93M | $-5M | $70M | $-539.0K | $-12M | $-3M | $3M | $-78M | $83M | $-12M | $-56M | $-17M | $85M | $-59M | $66M | |
| Free Cash Flow | · | · | · | · | · | $-27M | · | · | · | · | · | · | · | · | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.8% | -15.6% | · | -23.5% | -13.5% | -14.0% | · | -9.6% | -12.4% | -8.0% | · | -7.6% | -9.6% | -6.9% | · | -7.5% | |
| ROE | -26.5% | -19.6% | · | -28.3% | -15.8% | -15.6% | · | -10.7% | -13.9% | -8.7% | · | -8.6% | -11.2% | -8.0% | · | -8.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.3 | · | 4.1 | 5.5 | 7.5 | · | 13.1 | 10.9 | 18.0 | · | 15.0 | 14.6 | 14.2 | · | 13.5 | |
| Quick Ratio | 2.7 | 3.7 | · | 2.0 | 0.8 | 1.0 | · | 2.2 | 1.5 | 8.6 | · | 5.9 | 13.0 | 13.9 | · | 9.1 |
Bewertung (TTM) 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-136M | $-133M | · | $-119M | $-93M | $-81M | · | $-61M | $-54M | $-39M | · | $-32M | $-32M | $-32M | · | $-43M | |
| Market Cap | $317M | $467M | · | $276M | $185M | $138M | · | $418M | $463M | $484M | · | $173M | $135M | $196M | · | $138M | |
| P/E | -1.8 | -2.6 | · | -1.9 | -2.0 | -1.6 | · | -6.2 | -7.2 | -9.3 | · | -4.3 | -2.7 | -3.1 | · | -1.4 | |
| P/B | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Tangible Book | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -10.5 | · | · | · | -5.2 | · | · | · | -46.5 | · | · | · | -26.0 | · | · | |
| P / FCF | · | · | · | · | · | -5.2 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -56.4% | -38.2% | · | -53.2% | -50.2% | -60.9% | · | -16.2% | -13.9% | -10.8% | · | -23.3% | -37.7% | -32.7% | · | -70.3% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-166M | $-81M | $-37M | $-35M | $-51M |
| Verwässerte EPS | — | $-1.32 | $-0.84 | $-1.37 | $-2.95 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-113M | $-71M | $-34M | $-28M | $-42M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 179 Einreicher · $259.1M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 36 (-12 vs. Vorquartal) | 29 (+15 vs. Vorquartal) | 63 (+11 vs. Vorquartal) | 43 (+1 vs. Vorquartal) | +9.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | $108.601.271 | 35.606.974 | 41,91% | Aktien |
| Blue Owl Capital Holdings LP | $27.947.629 | 9.163.157 | 10,79% | Aktien |
| Defilade Capital Management, L.P. | $11.193.912 | 3.670.135 | 4,32% | Aktien |
| Driehaus Capital Management LLC | $9.648.440 | 3.163.423 | 3,72% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.073.448 | 2.974.901 | 3,50% | Aktien |
| RTW INVESTMENTS, LP | $7.826.297 | 2.565.999 | 3,02% | Aktien |
| DAFNA Capital Management LLC | $6.124.900 | 2.008.164 | 2,36% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.164.830 | 1.693.387 | 1,99% | Aktien |
| Qube Research & Technologies Ltd | $5.005.178 | 1.641.042 | 1,93% | Aktien |
| CITADEL ADVISORS LLC | $4.443.316 | 1.456.825 | 1,71% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.377.700 | 1.434.996 | 1,69% | Aktien |
| STATE STREET CORP | $4.306.002 | 1.411.804 | 1,66% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.279.675 | 1.403.172 | 1,65% | Aktien |
| Woodline Partners LP | $4.272.593 | 1.400.850 | 1,65% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $4.065.763 | 1.333.037 | 1,57% | Aktien |
| FMR LLC | $2.858.750 | 937.295 | 1,10% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $2.824.312 | 926.004 | 1,09% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $2.730.479 | 895.239 | 1,05% | Aktien |
| Alyeska Investment Group, L.P. | $1.882.494 | 617.211 | 0,73% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.580.815 | 518.300 | 0,61% | Verkaufsoption |
| VANGUARD FIDUCIARY TRUST CO | $1.366.912 | 448.168 | 0,53% | Aktien |
| Fi3 FINANCIAL ADVISORS, LLC | $1.263.896 | 2.915 | 0,49% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.218.604 | 399.542 | 0,47% | Aktien |
| MARSHALL WACE, LLP | $1.092.845 | 358.310 | 0,42% | Aktien |
| SummitTX Capital, L.P. | $1.074.466 | 352.284 | 0,41% | Aktien |
| Gem Investment Advisors, LLC | $974.533 | 319.519 | 0,38% | Aktien |
| Burkehill Global Management, LP | $915.000 | 300.000 | 0,35% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $907.201 | 297.443 | 0,35% | Aktien |
| HAP Trading, LLC | $848.766 | 262.776 | 0,33% | Aktien |
| ADAR1 Capital Management, LLC | $831.872 | 272.745 | 0,32% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $821.975 | 269.500 | 0,32% | Kaufoption |
| CITADEL ADVISORS LLC | $732.610 | 240.200 | 0,28% | Verkaufsoption |
| TWO SIGMA INVESTMENTS, LP | $720.206 | 236.133 | 0,28% | Aktien |
| Seven Fleet Capital Management LP | $704.309 | 230.921 | 0,27% | Aktien |
| HAP Trading, LLC | $687.173 | 237.776 | 0,27% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $631.255 | 206.969 | 0,24% | Aktien |
| IEQ CAPITAL, LLC | $620.258 | 203.363 | 0,24% | Aktien |
| Caption Management, LLC | $588.705 | 193.018 | 0,23% | Aktien |
| Soleus Capital Management, L.P. | $573.711 | 188.102 | 0,22% | Aktien |
| Cubist Systematic Strategies, LLC | $523.775 | 162.159 | 0,20% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $520.254 | 170.575 | 0,20% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $503.726 | 165.156 | 0,19% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $486.990 | 108.220 | 0,19% | Aktien |
| DIADEMA PARTNERS LP | $447.243 | 146.637 | 0,17% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $440.505 | 144.428 | 0,17% | Aktien |
| UBS Group AG | $440.194 | 144.326 | 0,17% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $421.498 | 138.196 | 0,16% | Aktien |
| Point72 Asset Management, L.P. | $411.158 | 134.806 | 0,16% | Aktien |
| Nuveen Asset Management, LLC | $366.137 | 94.609 | 0,14% | Aktien |
| Mariner, LLC | $349.099 | 114.445 | 0,13% | Aktien |
| Squarepoint Ops LLC | $346.096 | 113.474 | 0,13% | Aktien |
| Man Group plc | $344.799 | 113.049 | 0,13% | Aktien |
| TWO SIGMA ADVISERS, LP | $339.562 | 89.124 | 0,13% | Aktien |
| BlackRock, Inc. | $330.178 | 108.255 | 0,13% | Aktien |
| CWM, LLC | $288.567 | 64.126 | 0,11% | Aktien |
| ExodusPoint Capital Management, LP | $275.760 | 90.413 | 0,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $274.500 | 90.000 | 0,11% | Kaufoption |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $272.550 | 63.680 | 0,11% | Aktien |
| CARY STREET PARTNERS FINANCIAL LLC | $259.250 | 85.000 | 0,10% | Aktien |
| JANE STREET GROUP, LLC | $224.895 | 73.736 | 0,09% | Aktien |
| RHUMBLINE ADVISERS | $219.249 | 71.888 | 0,08% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $210.249 | 68.934 | 0,08% | Aktien |
| Quantbot Technologies LP | $209.752 | 68.771 | 0,08% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $182.353 | 59.788 | 0,07% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $182.085 | 59.700 | 0,07% | Aktien |
| SIMPLEX TRADING, LLC | $178.754 | 58.608 | 0,07% | Aktien |
| XTX Topco Ltd | $168.387 | 55.209 | 0,06% | Aktien |
| CIBC WORLD MARKET INC. | $161.650 | 53.000 | 0,06% | Aktien |
| PRUDENTIAL FINANCIAL INC | $160.805 | 52.723 | 0,06% | Aktien |
| WINTON GROUP Ltd | $159.820 | 52.400 | 0,06% | Aktien |
| JOURNEY STRATEGIC WEALTH LLC | $158.670 | 35.260 | 0,06% | Aktien |
| FEDERATED HERMES, INC. | $152.579 | 50.026 | 0,06% | Aktien |
| BANK OF AMERICA CORP /DE/ | $145.190 | 47.603 | 0,06% | Aktien |
| Pale Fire Capital SE | $131.150 | 43.000 | 0,05% | Aktien |
| JPMORGAN CHASE & CO | $130.336 | 40.730 | 0,05% | Aktien |
| Next Level Private LLC | $127.185 | 41.700 | 0,05% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $125.709 | 41.216 | 0,05% | Aktien |
| HAP Trading, LLC | $121.388 | 373.500 | 0,05% | Kaufoption |
| MetLife Investment Management, LLC | $121.384 | 39.798 | 0,05% | Aktien |
| HighTower Advisors, LLC | $114.979 | 37.698 | 0,04% | Aktien |
| Persistent Asset Partners Ltd | $113.991 | 37.374 | 0,04% | Aktien |
| DEUTSCHE BANK AG\ | $111.569 | 36.580 | 0,04% | Aktien |
| Velan Capital Investment Management LP | $100.650 | 33.000 | 0,04% | Aktien |
| CITIGROUP INC | $96.972 | 31.794 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $93.489 | 30.652 | 0,04% | Aktien |
| Bank of New York Mellon Corp | $92.510 | 30.331 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $86.010 | 28.200 | 0,03% | Verkaufsoption |
| STRS OHIO | $80.825 | 26.500 | 0,03% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $80.724 | 26.467 | 0,03% | Aktien |
| VANGUARD GROUP INC | $80.189 | 21.047 | 0,03% | Aktien |
| Invesco Ltd. | $79.669 | 26.121 | 0,03% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $76.894 | 25.211 | 0,03% | Aktien |
| Russell Investments Group, Ltd. | $76.756 | 25.166 | 0,03% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $70.350 | 23.067 | 0,03% | Aktien |
| Cerity Partners LLC | $70.081 | 22.977 | 0,03% | Aktien |
| Engineers Gate Manager LP | $68.799 | 22.557 | 0,03% | Aktien |
| Cherry Tree Wealth Management, LLC | $68.688 | 15.264 | 0,03% | Aktien |
| Vanguard Global Advisers, LLC | $64.193 | 21.047 | 0,02% | Aktien |
| Walleye Trading LLC | $61.000 | 20.000 | 0,02% | Aktien |
| CITADEL ADVISORS LLC | $60.695 | 19.900 | 0,02% | Kaufoption |
Unternehmensinsider 28 Insider · 12 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Carole Ben-Maimon | President and CEO | 26. Januar 2026 A | 368.276 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Chief Executive Officer | 22. Januar 2019 A | — | 0 | 0 | $0 |
| Michael Celano | Chief Financial Officer | 26. Januar 2026 A | 215.785 | 0 | 0 | $0 |
| Patricia L Allen | Chief Financial Officer | 22. Januar 2019 A | 19.793 | 0 | 0 | $0 |
| Thomas E. Hughes | President and Chief Scientific Officer | 28. Juni 2018 S | 125.247 | 0 | 0 | $0 |
| Patrick Loustau | President | 31. März 2016 A | — | 0 | 0 | $0 |
| Gopi Shankar | Chief Development Officer | 26. Januar 2026 A | 76.443 | 0 | 0 | $0 |
| Russell Clayton | Chief Medical Officer | 26. Januar 2026 A | 71.443 | 0 | 0 | $0 |
| Singhal Priya | Head of Research & Development | 2. April 2019 A | — | 0 | 0 | $0 |
| Brian Mcveigh | Chief Business Officer | 22. Januar 2019 A | — | 0 | 0 | $0 |
| Dennis D Kim | Chief Medical Officer | 22. Januar 2019 A | 21.443 | 0 | 0 | $0 |
| Alicia Secor | Chief Commercial Officer | 31. März 2016 A | 0 | 0 | 0 | $0 |
| Thomas Edward Hamilton | Direktor | 6. Juli 2026 P | 714.798 | 2 | 0 | $667.000 |
| Joseph Truitt | Direktor | 19. Mai 2026 A | 2.750 | 0 | 0 | $0 |
| Frank E Thomas | Direktor | 19. Mai 2026 A | 7.000 | 1 | 0 | $25.000 |
| Jeffrey W Sherman | Direktor | 19. Mai 2026 A | 5.000 | 1 | 0 | $25.000 |
| Jonathan S Leff | Direktor | 19. Mai 2026 A | — | 0 | 0 | $0 |
| Peter Barrett | Direktor | 10. Mai 2022 A | 4.643.327 | 0 | 0 | $0 |
| Thomas O Daniel | Direktor | 12. Mai 2021 A | 19.452 | 0 | 0 | $0 |
| Wendy Everett | Direktor | 26. Juni 2019 A | — | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Direktor | 26. Juni 2019 A | 0 | 0 | 0 | $0 |
| Robert J Perez | Direktor | 26. Juni 2019 A | 5.322 | 0 | 0 | $0 |
| John L Lamattina | Direktor | 26. Juni 2019 A | 31.376 | 0 | 0 | $0 |
| Bruce Booth | Direktor | 3. Januar 2018 A | 4.638.028 | 0 | 0 | $0 |
| Frances K Heller | Direktor | 13. Oktober 2017 P | 47.961 | 0 | 0 | $0 |
| Kevin P Starr | Direktor | 24. September 2015 J | 370.323 | 0 | 0 | $0 |
| Avi Y. Goldberg | Direktor | 18. September 2015 S | 53.734 | 0 | 0 | $0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 10%-Eigentümer | 26. Juni 2020 J | 8 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., James E. Flynn ×12 Einreichungen | 2. März 2026 | 34,41% | Änderung | — | SEC |
| Chondrial Therapeutics Holdings, LLC ×2 Einreichungen | 30. Juni 2020 | — | Erste Einreichung | — | SEC |
| Chondrial Therapeutics, Inc. | 27. Dezember 2019 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 29 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,22% | 4.010 SH | 8. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,14% | 93.475 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,06% | 227.318 SH | 8. August 2026 | Täglich |
| FSCC · Federated Hermes ETF Trust | 0,06% | 47.062 NS | 31. Mai 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 5.600 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,02% | 4.014 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,02% | 609.989 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 382.933 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 382.844 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 71.780 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 316.227 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.689.750 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 20.396 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 2.221 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 24.913 NS | 31. Mai 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 12.923 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1.737 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1.755 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.906 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 1.788 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 44 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.196 SH | 8. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 11.156 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 12.332 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 699.471 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.206.446 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.400 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 1.156 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 172.125 SH | 8. August 2026 | Täglich |